E. Carde, The French Health Care System Challenged by the Over-Sea??: Some Inequalities in French Guyana, Espace populations soci??t??s, issue.2009/1, pp.175-189, 2001.
DOI : 10.4000/eps.3638

E. Lauret, Tableaux économiques régionaux de la Guyane, pp.12-13, 2010.

V. Vantilcke, fièvre au cours le l'infection par le VIH dans l'ouest Guyanais, 2010.

C. Camesella and H. B. , La Communaité de Communes de l'Ouest Guyanais : un territoire jeune et attractif à développer, INSEE, 2009.

D. Vernon, Choses de la forêt, Identité et thérapie chez les Noirs Marrons Ndjuka du Surinam, pp.261-281, 1993.

M. Nacher, Rapport d'activité CISIH 2006 : point sur la prise en charge du VIH en Guyane, 2007.

K. R. Robertson, Pattern of neuropsychological performance among HIV positive patients in Uganda, BMC Neurology, vol.33, issue.1, p.8, 2007.
DOI : 10.1097/00126334-200305010-00018

J. Gasnault, « Comment dépister et prendre en charge les troubles neuro-cognitifs? »Quels enjeux pour les patients VIH ?, in X ème Congrès National de la Société Françaisede Lutte contre le Sida, SFLS, 2009.

K. R. Robertson, The prevalence and incidence of neurocognitive impairment in the HAART era, AIDS, vol.21, issue.14, pp.1915-1936, 2007.
DOI : 10.1097/QAD.0b013e32828e4e27

J. C. Mcarthur, Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy, Archives of Neurology, vol.61, issue.11, pp.61-1687, 2004.
DOI : 10.1001/archneur.61.11.1687

A. Antinori, Updated research nosology for HIV-associated neurocognitive disorders, OMS, VIH/Sida et santé mentale, pp.69-1789, 2007.
DOI : 10.1212/01.WNL.0000287431.88658.8b

C. H. Hinkin, Medication adherence in HIV-infected adults, AIDS, vol.18, issue.Supplement 1, pp.19-25, 2004.
DOI : 10.1097/00002030-200401001-00004

P. Yeni, prise en charge médicale des personnes infectées par le VIH. 2010, la documentation française, pp.132-134

B. J. Brew, The International AIDS Society?USA: Washington. 16 Neurodegeneration and ageing in the HAART era, Decades On J Neuroimmune Pharmacol, issue.42, pp.163-74, 2009.

S. Letendre, F. C. Ellis, and R. , Correlates of CSF viral loads in 1221 volunteers of the CHARTER Cohort, 17th CROI 2010. Abstract 172, 2010.

J. Gasnault and N. J. Haughey, Système nerveux et VIH : «Charter» pour la CROI. Transcriptase, 2009. 141. 19 Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia, Ann Neurol, issue.2, pp.55-257, 2004.

V. Biscay, Troubles neurocognitifs dans le VIH, 2010.

. Poissonet, les tests cognitifs : éléments de diagnostic et de suivi, in pourquoi et comment traiter un patient agé dément ?, p.22, 2008.

A. Jolivet, Migrations et soins en Guyane Agence française de développement, p.31, 2009.

N. C. Sacktor, The International HIV Dementia Scale: a new rapid screening test for HIV dementia, Aids, vol.19, issue.13, pp.1367-74, 2005.

R. Heaton, and progression of HIV-associated neurocognitive impairment (NCI) in the era of combination antiretroviral therapy (CART) and the role of comorbidities: the CHARTER study, 5th IAS Conference on HIV Pathogenesis and Treatment, 2009.

A. K. Njamnshi, The International HIV Dementia Scale Is a Useful Screening Tool for HIV-Associated Dementia/Cognitive Impairment in HIV-Infected Adults in Yaound??-Cameroon, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.49, issue.4, 2008.
DOI : 10.1097/QAI.0b013e318183a9df

K. Lawler, Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study 13: p. 15. 27 Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection High prevalence of mild neurocognitive disorders in HIV-infected patients, ANRS CO3 Aquitaine Cohort, 16th CROI 2009 Abstract 474, pp.488-922, 1996.

A. L. Pitel, Episodic and Working Memory Deficits in Alcoholic Korsakoff Patients: The Continuity Theory Revisited, Alcoholism: Clinical and Experimental Research, vol.34, issue.Pt 1A, pp.32-1229, 2008.
DOI : 10.1111/j.1530-0277.2008.00677.x

B. Shiramizu, HIV DNA and Dementia in Treatment-Na??ve HIV-1-Infected Individuals in Bangkok, Thailand, International Journal of Medical Sciences, vol.4, issue.1, pp.13-21, 2007.
DOI : 10.7150/ijms.4.13

C. M. Marra, Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance, AIDS, vol.23, issue.11, pp.1359-66, 2009.
DOI : 10.1097/QAD.0b013e32832c4152

L. A. Cysique, Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy, Neurology, vol.73, issue.5, pp.342-350, 2009.
DOI : 10.1212/WNL.0b013e3181ab2b3b

R. K. Heaton, The impact of HIV-associated neuropsychological impairment on everyday functioning, Journal of the International Neuropsychological Society, vol.56, issue.03, pp.317-348, 2004.
DOI : 10.1016/0887-6177(93)E0005-V